A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

NCT01589432 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathic Pain

Interventions

DRUG: ABT-639
DRUG: Placebo
DRUG: Lidocaine

Sponsor

AbbVie (prior sponsor, Abbott)